RGLFX
Price
$27.68
Change
-$0.27 (-0.97%)
Updated
Nov 18 closing price
Net Assets
18.8B
RWICX
Price
$74.06
Change
-$0.67 (-0.90%)
Updated
Nov 18 closing price
Net Assets
139.93B
Interact to see
Advertisement

RGLFX vs RWICX

Header iconRGLFX vs RWICX Comparison
Open Charts RGLFX vs RWICXBanner chart's image
American Funds Global Insight R-5
Price$27.68
Change-$0.27 (-0.97%)
VolumeN/A
Net Assets18.8B
American Funds Capital World Gr&Inc R3
Price$74.06
Change-$0.67 (-0.90%)
VolumeN/A
Net Assets139.93B
RGLFX vs RWICX Comparison Chart in %
View a ticker or compare two or three
VS
RGLFX vs. RWICX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGLFX is a Hold and RWICX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 140B vs. RGLFX (18.8B). RWICX pays higher dividends than RGLFX: RWICX (1.11) vs RGLFX (1.00). RGLFX was incepted earlier than RWICX: RGLFX (6 years) vs RWICX (23 years). RWICX (1.06) is less costly to investors than RGLFX (0.50). RWICX is a more actively managed with annual turnover of: 27.00 vs. RGLFX (21.00). RGLFX (250) and RWICX (250) have matching initial minimum investment requirements. RGLFX annual gain was more profitable for investors over the last year : 17.52 vs. RWICX (11.78). RGLFX return over 5 years is better than : 55.67 vs. RWICX (39.85).
RGLFXRWICXRGLFX / RWICX
Total Expense Ratio0.501.0647%
Annual Report Gross Expense Ratio0.501.0647%
Fund Existence6 years23 years-
Gain YTD18.39218.54499%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets18.8B140B13%
Annual Yield % from dividends1.001.1190%
Returns for 1 year17.5211.78149%
Returns for 3 years54.5149.34110%
Returns for 5 years55.6739.85140%
Returns for 10 yearsN/A71.76-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNDA5.340.94
+21.36%
Vanda Pharmaceuticals
GRCE3.160.16
+5.33%
Grace Therapeutics Inc
PATH13.740.22
+1.63%
UiPath
FTAIN25.690.18
+0.73%
FTAI Aviation Ltd
COLL45.31-0.03
-0.07%
Collegium Pharmaceutical